Impact of an Educational Program on Efficacy and Adherence with a Twice-Daily Lamivudine/Zidovudine/Abacavir Regimen in Underrepresented HIV-Infected Patients. Journal of Acquired Immune Deficiency Syndromes, 34(2): 174-183.

In by AHF

Tipranavir: A Novel Second-Generation Nonpeptidic Protease Inhibitor. Expert Review of Anti-Infective Therapy, 3(1): 9-21.
Pancreatitis Treated with Didanosine and Tenofovir Disoproxil Fumarate. Clinical Infectious Diseases, 37(5): e57-e62.
Download
File Type: pdf
File Size: 7 MB
Categories: 2003
Tags: 1999-2009
Author: Brown LS, Crawford KH, Farthing CF, Goodwin DS, Racine JM, Rawlings KM, RC, Scott, Shafer MS, Thompson MA, Tolson JM, Williams VC